×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MAZE – maze therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MAZE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/9
07:16 am
maze
What to Know About One Maze Insider's $3 Million Stock Sale as Shares Surge 150% [Yahoo! Finance]
Medium
Report
What to Know About One Maze Insider's $3 Million Stock Sale as Shares Surge 150% [Yahoo! Finance]
1/5
07:13 am
maze
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
maze
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/22
06:55 am
maze
We Think Maze Therapeutics (NASDAQ:MAZE) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
Low
Report
We Think Maze Therapeutics (NASDAQ:MAZE) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
12/19
09:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/19
05:58 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
12/13
01:11 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wall Street
Low
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wall Street
12/9
08:11 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/9
04:51 pm
maze
Form 4 Maze Therapeutics, Inc. For: Jan 07 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Jan 07 Filed by: Bernstein Harold
1/8
04:31 pm
maze
Form 4 Maze Therapeutics, Inc. For: Jan 06 Filed by: Sohn Catherine A.
Low
Report
Form 4 Maze Therapeutics, Inc. For: Jan 06 Filed by: Sohn Catherine A.
1/7
04:01 pm
maze
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
Medium
Report
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
1/6
04:36 pm
maze
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
Medium
Report
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
1/6
04:32 pm
maze
Form 4 Maze Therapeutics, Inc. For: Jan 02 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Jan 02 Filed by: Bernstein Harold
1/6
04:31 pm
maze
Form 4 Maze Therapeutics, Inc. For: Jan 02 Filed by: Bachrodt Amy
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Jan 02 Filed by: Bachrodt Amy
12/31
04:24 pm
maze
Form 4 Maze Therapeutics, Inc. For: Dec 29 Filed by: Dandekar Atul
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Dec 29 Filed by: Dandekar Atul
12/31
04:23 pm
maze
Form 4 Maze Therapeutics, Inc. For: Dec 29 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Dec 29 Filed by: Bernstein Harold
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: